These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34529945)

  • 1. The importance of the design of observational studies in comparative effectiveness research: Lessons from the GARFIELD-AF and ORBIT-AF registries.
    Farjat AE; Virdone S; Thomas LE; Kakkar AK; Pieper KS; Piccini JP
    Am Heart J; 2022 Jan; 243():110-121. PubMed ID: 34529945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
    Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
    Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries.
    Steinberg BA; Gao H; Shrader P; Pieper K; Thomas L; Camm AJ; Ezekowitz MD; Fonarow GC; Gersh BJ; Goldhaber S; Haas S; Hacke W; Kowey PR; Ansell J; Mahaffey KW; Naccarelli G; Reiffel JA; Turpie A; Verheugt F; Piccini JP; Kakkar A; Peterson ED; Fox KAA; ;
    Am Heart J; 2017 Dec; 194():132-140. PubMed ID: 29223431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation (GARFIELD-AF).
    Fox KAA; Accetta G; Pieper KS; Bassand JP; Camm AJ; Fitzmaurice DA; Kayani G; Kakkar AK;
    Eur Heart J Qual Care Clin Outcomes; 2018 Jan; 4(1):27-35. PubMed ID: 28950344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke prevention in atrial fibrillation patients in Poland and other European countries: insights from the GARFIELD-AF registry.
    Stępińska J; Kremis E; Konopka A; Wożakowska-Kapłon B; Ruszkowski P; Kukla P; Kayani G
    Kardiol Pol; 2016; 74(4):362-71. PubMed ID: 26365937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation.
    Fox KAA; Lucas JE; Pieper KS; Bassand JP; Camm AJ; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Hacke W; Kayani G; Oto A; Mantovani LG; Misselwitz F; Piccini JP; Turpie AGG; Verheugt FWA; Kakkar AK;
    BMJ Open; 2017 Dec; 7(12):e017157. PubMed ID: 29273652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GARFIELD-AF: a worldwide prospective registry of patients with atrial fibrillation at risk of stroke.
    Bassand JP; Apenteng PN; Atar D; Camm AJ; Cools F; Corbalan R; Fitzmaurice DA; Fox KA; Goto S; Haas S; Hacke W; Jerjes-Sanchez C; Koretsune Y; Heuzey JL; Sawhney JP; Oh S; Stępińska J; Cate VT; Verheugt FW; Kayani G; Pieper KS; Kakkar AK; Garfield-Af Investigators FT
    Future Cardiol; 2021 Jan; 17(1):19-38. PubMed ID: 32696663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF.
    Haas S; Camm AJ; Bassand JP; Angchaisuksiri P; Cools F; Corbalan R; Gibbs H; Jacobson B; Koretsune Y; Mantovani LG; Misselwitz F; Panchenko E; Ragy HI; Stepinska J; Turpie AG; Sawhney JP; Steffel J; Lim TW; Pieper KS; Virdone S; Verheugt FW; Kakkar AK;
    Am Heart J; 2019 Jul; 213():35-46. PubMed ID: 31128503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.
    Sawhney JP; Kothiwale VA; Bisne V; Durgaprasad R; Jadhav P; Chopda M; Vanajakshamma V; Meena R; Vijayaraghavan G; Chawla K; Allu J; Pieper KS; John Camm A; Kakkar AK;
    Indian Heart J; 2018; 70(6):828-835. PubMed ID: 30580852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning does not improve upon traditional regression in predicting outcomes in atrial fibrillation: an analysis of the ORBIT-AF and GARFIELD-AF registries.
    Loring Z; Mehrotra S; Piccini JP; Camm J; Carlson D; Fonarow GC; Fox KAA; Peterson ED; Pieper K; Kakkar AK
    Europace; 2020 Nov; 22(11):1635-1644. PubMed ID: 32879969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation.
    Huisman MV; Lip GY; Diener HC; Dubner SJ; Halperin JL; Ma CS; Rothman KJ; Teutsch C; Zint K; Ackermann D; Clemens A; Bartels DB
    Am Heart J; 2014 Mar; 167(3):329-34. PubMed ID: 24576516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
    Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
    BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry.
    Haas S; Ten Cate H; Accetta G; Angchaisuksiri P; Bassand JP; Camm AJ; Corbalan R; Darius H; Fitzmaurice DA; Goldhaber SZ; Goto S; Jacobson B; Kayani G; Mantovani LG; Misselwitz F; Pieper K; Schellong SM; Stepinska J; Turpie AG; van Eickels M; Kakkar AK;
    PLoS One; 2016; 11(10):e0164076. PubMed ID: 27792741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registry.
    Oh S; Goto S; Accetta G; Angchaisuksiri P; Camm AJ; Cools F; Haas S; Kayani G; Koretsune Y; Lim TW; Misselwitz F; van Eickels M; Kakkar AK;
    Int J Cardiol; 2016 Nov; 223():543-547. PubMed ID: 27552578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GARFIELD-AF model for prediction of stroke and major bleeding in atrial fibrillation: a Danish nationwide validation study.
    Dalgaard F; Pieper K; Verheugt F; Camm AJ; Fox KA; Kakkar AK; Pallisgaard JL; Rasmussen PV; Weert HV; Lindhardt TB; Torp-Pedersen C; Gislason GH; Ruwald MH; Harskamp RE
    BMJ Open; 2019 Nov; 9(11):e033283. PubMed ID: 31719095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction to target trial emulation in rehabilitation: a systematic approach to emulate a randomized controlled trial using observational data.
    Côté P; Negrini S; Donzelli S; Kiekens C; Arienti C; Ceravolo MG; Gross DP; Battel I; Ferriero G; Lazzarini SG; Dan B; Shearer HM; Wong JJ;
    Eur J Phys Rehabil Med; 2024 Feb; 60(1):145-153. PubMed ID: 38420907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dabigatran in real-world atrial fibrillation. Meta-analysis of observational comparison studies with vitamin K antagonists.
    Carmo J; Moscoso Costa F; Ferreira J; Mendes M
    Thromb Haemost; 2016 Sep; 116(4):754-63. PubMed ID: 27465747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry.
    Jerjes-Sanchez C; Corbalan R; Barretto ACP; Luciardi HL; Allu J; Illingworth L; Pieper KS; Kayani G;
    Clin Cardiol; 2019 May; 42(5):553-560. PubMed ID: 30873623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry.
    Apenteng PN; Gao H; Hobbs FR; Fitzmaurice DA;
    BMJ Open; 2018 Jan; 8(1):e018905. PubMed ID: 29331969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD).
    Kakkar AK; Mueller I; Bassand JP; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Hacke W; Lip GY; Mantovani LG; Verheugt FW; Jamal W; Misselwitz F; Rushton-Smith S; Turpie AG
    Am Heart J; 2012 Jan; 163(1):13-19.e1. PubMed ID: 22172431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.